Latest International Expansion News

Bailador Technology Investments has updated its portfolio valuations, revealing strong gains in key holdings and a projected gross return of 32.8% for FY25. However, one investment saw a significant decline, tempering overall optimism.

Collins Foods delivered resilient FY25 results with solid revenue growth and a strategic pivot towards German market expansion, while addressing profitability challenges in the Netherlands.

Ionic Rare Earths is advancing plans for multiple magnet recycling plants in the US, leveraging patented technology to produce high-purity rare earth oxides amid growing demand for sovereign supply chains.

xReality Group is rapidly transforming its business by focusing on its high-growth Operator XR training platform, while preparing to divest legacy entertainment assets. The company reports record revenue and expanding global reach, particularly in the US defence and law enforcement sectors.

EZZ Life Science has launched its US-focused brand EZZDAY with four FDA-registered supplements, marking a major step in its international growth strategy. The company has also begun US-based manufacturing and opened an online store to target American consumers.

Viva Leisure has launched a refreshed corporate brand and published 'The Viva Story,' outlining its transformation into a global, technology-driven fitness ecosystem.

Ionic Rare Earths is broadening its Viridion Joint Venture to include a US-based rare earth refinery, aiming to strengthen a secure supply chain for critical magnet and heavy rare earth oxides outside China.

Bioxyne Limited's subsidiary Breathe Life Sciences has achieved key GMP certifications across multiple international markets, paving the way for expanded operations in Europe, the UK, Canada, and Singapore. The company signals strong growth prospects for FY2026, with formal guidance expected in August.

Bioxyne Limited has raised its FY2025 revenue guidance to $28 million, driven by explosive growth in Australian pharmaceutical manufacturing and the upcoming commercial production of MDMA capsules. The company is also making strides in expanding its footprint across Europe.

Firebrick Pharma has unexpectedly withdrawn its planned share placement, raising questions about its capital strategy amid ongoing product launches.

Anagenics Limited’s proprietary hair regrowth technology powers the newly launched Bouf Haircare brand, which has achieved over $500,000 in sales in its first week, setting the stage for a lucrative royalty stream.

Beamtree Holdings has forged a strategic alliance with the NHS Confederation to launch a pioneering healthcare analytics platform across UK NHS Trusts, marking a significant step in its international expansion.